{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bish LT"],"funding":["NCRR NIH HHS","NHLBI NIH HHS","NIAMS NIH HHS"],"pagination":["969-77"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3159526"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(8)"],"pubmed_abstract":["Derangements in calcium cycling have been described in failing hearts, and preclinical studies have suggested that therapies aimed at correcting this defect can lead to improvements in cardiac function and survival. One strategy to improve calcium cycling would be to inhibit phospholamban (PLB), the negative regulator of SERCA2a that is upregulated in failing hearts. The goal of this study was to evaluate the safety and efficacy of using adeno-associated virus (AAV)-mediated cardiac gene transfer of short hairpin RNA (shRNA) to knock down expression of PLB. Six dogs were treated with self-complementary AAV serotype 6 (scAAV6) expressing shRNA against PLB. Three control dogs were treated with empty AAV6 capsid, and two control dogs were treated with scAAV6 expressing dominant negative PLB. "],"journal":["Human gene therapy"],"pubmed_title":["Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines."],"pmcid":["PMC3159526"],"funding_grant_id":["P01-HL059407","U54-AR052646","RR02512","T32-HL-007748"],"pubmed_authors":["Bish LT","Sleeper MM","Gazzara J","Wilson JM","Sweeney HL","Singletary GE","Buchlis G","Withnall E","Gao G","Reynolds C","High KA","Hui D"],"additional_accession":[]},"is_claimable":false,"name":"Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines.","description":"Derangements in calcium cycling have been described in failing hearts, and preclinical studies have suggested that therapies aimed at correcting this defect can lead to improvements in cardiac function and survival. One strategy to improve calcium cycling would be to inhibit phospholamban (PLB), the negative regulator of SERCA2a that is upregulated in failing hearts. The goal of this study was to evaluate the safety and efficacy of using adeno-associated virus (AAV)-mediated cardiac gene transfer of short hairpin RNA (shRNA) to knock down expression of PLB. Six dogs were treated with self-complementary AAV serotype 6 (scAAV6) expressing shRNA against PLB. Three control dogs were treated with empty AAV6 capsid, and two control dogs were treated with scAAV6 expressing dominant negative PLB. ","dates":{"release":"2011-01-01T00:00:00Z","publication":"2011 Aug","modification":"2025-04-27T02:21:49.717Z","creation":"2019-03-27T00:43:11Z"},"accession":"S-EPMC3159526","cross_references":{"pubmed":["21542669"],"doi":["10.1089/hum.2011.035"]}}